Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Envestnet Asset Management Inc. Has $23.76 Million Stock Position in Global Payments Inc. $GPN
03:57am, Tuesday, 04'th Nov 2025
Envestnet Asset Management Inc. decreased its holdings in shares of Global Payments Inc. (NYSE: GPN) by 23.9% in the undefined quarter, according to the company in its most recent disclosure with the
Remitly Global, Inc. $RELY Shares Bought by Teacher Retirement System of Texas
03:55am, Tuesday, 04'th Nov 2025
Teacher Retirement System of Texas grew its holdings in Remitly Global, Inc. (NASDAQ: RELY) by 63.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC.
AlTi Global Inc. Grows Position in Meta Platforms, Inc. $META
03:49am, Tuesday, 04'th Nov 2025
AlTi Global Inc. lifted its stake in shares of Meta Platforms, Inc. (NASDAQ: META) by 26.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm own
Alphabet Inc. $GOOGL Shares Purchased by AlTi Global Inc.
03:48am, Tuesday, 04'th Nov 2025
AlTi Global Inc. boosted its stake in Alphabet Inc. (NASDAQ: GOOGL) by 1.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 252,633 shares of the inform
Allspring Global Investments Holdings LLC Trims Stock Holdings in Amazon.com, Inc. $AMZN
03:45am, Tuesday, 04'th Nov 2025
Allspring Global Investments Holdings LLC reduced its position in Amazon.com, Inc. (NASDAQ: AMZN) by 1.8% during the second quarter, according to the company in its most recent 13F filing with the SEC
PTT Global Chemical Public (OTCMKTS:PGCPF) Shares Down 2.9% – Here’s What Happened
02:50am, Tuesday, 04'th Nov 2025
PTT Global Chemical Public Company Limited (OTCMKTS:PGCPF - Get Free Report)'s share price fell 2.9% during trading on Monday. The stock traded as low as $0.68 and last traded at $0.68. 7,934 shares t
Kolibri Global Energy (TSE:KEI) Trading Down 1.7% – What’s Next?
02:50am, Tuesday, 04'th Nov 2025
Shares of Kolibri Global Energy Inc. (TSE: KEI - Get Free Report) fell 1.7% during trading on Monday. The company traded as low as C$5.96 and last traded at C$5.96. 11,355 shares were traded during tr
HarbourVest Global Private Equity (OTCMKTS:HVPQF) Stock Price Up 10.5% – Here’s What Happened
02:50am, Tuesday, 04'th Nov 2025
HarbourVest Global Private Equity Ltd. (OTCMKTS:HVPQF - Get Free Report)'s stock price was up 10.5% on Monday. The stock traded as high as $37.81 and last traded at $37.56. Approximately 720 shares tr
Global X Lithium & Battery Tech ETF (NYSEARCA:LIT) Short Interest Up 60.0% in October
02:49am, Tuesday, 04'th Nov 2025
Global X Lithium and Battery Tech ETF (NYSEARCA:LIT - Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest
VH Global Sustainable Energy Opportunities (LON:GSEO) Shares Down 0.9% – Here’s Why
02:49am, Tuesday, 04'th Nov 2025
VH Global Sustainable Energy Opportunities plc (LON: GSEO - Get Free Report)'s stock price traded down 0.9% on Monday. The stock traded as low as GBX 67 and last traded at GBX 67. 290,577 shares were
Remitly Global Set to Report Q3 Earnings: What's in Store?
12:01am, Tuesday, 04'th Nov 2025
RELY aims for strong third-quarter 2025 growth, driven by rising send volumes, digital momentum and new U.S. expansion.
Zeta Global Set to Report Q3 Earnings: What's in the Offing?
12:01am, Tuesday, 04'th Nov 2025
ZETA's AI-driven platform and new tools like Zeta Answers and OneZeta are expected to fuel strong third-quarter 2025 growth.
XCF Global and Impact Jets Sign MOU to Supply Private Jet Market with Sustainable Aviation Fuel
06:25pm, Monday, 03'rd Nov 2025
Expands XCF's reach to the ~$17 billion U.S. private aviation market Develops new growth channel through Impact Jets' network of ~130 operators Accelerates adoption by bringing verifiable, traceable S
Bristol-Myers Squibb: Increased Global Breyanzi Sales Isn't Only Hematological Product Growth
06:06pm, Monday, 03'rd Nov 2025
Bristol-Myers Squibb (BMY) remains a "Strong Buy" rating, driven by robust growth in its hematology and cardiovascular portfolios, especially Breyanzi and Camzyos. Breyanzi and Reblozyl achieved impre
-- Every two weeks remains approved as a dosing regimen of Elfabrio in the EU -- -- Every two weeks remains approved as a dosing regimen of Elfabrio in the EU --
